Virtual IBD Clinic: Surgical and Pharmacological Therapeutics

Activity Overview

It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In this interactive CME activity, Dr. Sauk presents the case of a patient with CD, highlighting the importance of early recognition of disease complications and considerations for surgical management. This real-world patient case offers you an opportunity to test your clinical skills for the successful management of inflammatory bowel disease (IBD) and learn more from an IBD expert faculty.

0.75 CE Credit(s)
Expires: December 12, 2023

Target Audience

Primary care physicians, gastroenterologists, nurse practitioners, and physician assistants engaged in the care of patients with inflammatory bowel disease (IBD).

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Decide which medical treatment to use in acute IBD flares and for long-term disease management
  • Identify IBD characteristics for which surgery is indicated

Activity Faculty

Jenny S Sauk MD

Jenny S. Sauk, MD

Associate Professor, Vatche and Tamar Manoukian Division of
Digestive Diseases

Department of Medicine
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA

Provider Statement

This activity is jointly provided by RMEI Medical Education, LLC and the Crohn’s & Colitis Foundation.

Supporter Statement

This activity is supported by educational grants from AbbVie Inc., Coherus BioSciences, and Takeda Pharmaceuticals U.S.A., Inc.

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources